Objective: To assess pathological, biochemical and clinical parameters in HCC patients with low, normal and high AFP levels. Methodology: This comparative analytical study was conducted in Liver and Gastric Clinic, Holy Family Hospital, Rawalpindi from June 2019-June 2020.Sample size was calculated as 225 by WHO sample size calculator . Non randomized convenient sampling was used. Patients were divided into three groups according to AFP values; <200 ng/ml, 200-400ng/ml and >400 ng/ml. Patients demographic details, medical history, clinical symptoms and signs, biochemical parameters and pathological findings on ultrasonography and CECT were assessed. Data was analyzed by SPSS version 21. Descriptive statistics were calculated for cat...
BACKGROUND: alpha-Fetoprotein (AFP) is a biomarker commonly used in the management of patients with ...
α-Fetoprotein (AFP) is a biomarker commonly used in the management of patients with hepatocellular c...
Background: Hepatocellular carcinoma is the commonest primary liver malignancy worldwide, with a hig...
Objective: To assess pathological, biochemical and clinical parameters in HCC patients with low, nor...
Background: Hepatocellular carcinoma (HCC) is one of the leading causes of cancer-related deaths wor...
Objective: To determine the association between high levels of serum Alpha Fetoprotein (AFP) and tum...
Objective: To determine the association between serum Alpha-Fetoprotein (AFP) levels with diff...
Objective: To assess the diagnostic significance of α-fetoprotein in carcinomas of liver and biliary...
Objectives: To determine the frequency of deaths in hepatitis C virus infected hepatocellular carcin...
Objective: To assess the correlation between the Alpha-fetoprotein (AFP) level and characteristics o...
AIM: To investigate the biological role of alpha fetoprotein (AFP) and its clinical significance in ...
SummaryObjectivesThe prevalence of hepatitis B virus (HBV) is reportedly the main cause of hepatocel...
A recent study from the US showed a decreasing trend in the elevated serum alpha-fetoprotein (AFP) l...
Chronic hepatitis C (CHC) shows a significant association with cirrhosis and hepatocellular carcinom...
Objective: To determine whether there was a correlation between tumor size and alpha feto-protein (...
BACKGROUND: alpha-Fetoprotein (AFP) is a biomarker commonly used in the management of patients with ...
α-Fetoprotein (AFP) is a biomarker commonly used in the management of patients with hepatocellular c...
Background: Hepatocellular carcinoma is the commonest primary liver malignancy worldwide, with a hig...
Objective: To assess pathological, biochemical and clinical parameters in HCC patients with low, nor...
Background: Hepatocellular carcinoma (HCC) is one of the leading causes of cancer-related deaths wor...
Objective: To determine the association between high levels of serum Alpha Fetoprotein (AFP) and tum...
Objective: To determine the association between serum Alpha-Fetoprotein (AFP) levels with diff...
Objective: To assess the diagnostic significance of α-fetoprotein in carcinomas of liver and biliary...
Objectives: To determine the frequency of deaths in hepatitis C virus infected hepatocellular carcin...
Objective: To assess the correlation between the Alpha-fetoprotein (AFP) level and characteristics o...
AIM: To investigate the biological role of alpha fetoprotein (AFP) and its clinical significance in ...
SummaryObjectivesThe prevalence of hepatitis B virus (HBV) is reportedly the main cause of hepatocel...
A recent study from the US showed a decreasing trend in the elevated serum alpha-fetoprotein (AFP) l...
Chronic hepatitis C (CHC) shows a significant association with cirrhosis and hepatocellular carcinom...
Objective: To determine whether there was a correlation between tumor size and alpha feto-protein (...
BACKGROUND: alpha-Fetoprotein (AFP) is a biomarker commonly used in the management of patients with ...
α-Fetoprotein (AFP) is a biomarker commonly used in the management of patients with hepatocellular c...
Background: Hepatocellular carcinoma is the commonest primary liver malignancy worldwide, with a hig...